-
Resolutions adopted by the Annual General Shareholders Meeting of Ryvu Therapeutics S.A.
Read More
August 31, 2020 -
Introduction of the Series I Shares to trading on the main market operated by the WSE and designation of the last day of listing of Rights to Series I Shares
Read More
August 26, 2020 -
Registration of share capital increase
Read More
August 19, 2020 -
Completion of the subscription of Series I Shares
Read More
August 5, 2020 -
Introduction of the Rights to Series I Shares to trading on the main market operated by the WSE
Read More
July 30, 2020 -
Registration of the Rights to Series I Shares in the book-entry form by the National Depository for Securities
Read More
July 27, 2020 -
Execution of subscription agreements and collection of cash contributions relating to series I shares in Ryvu Therapeutics S.A.
Read More
July 22, 2020 -
Determination of the issue price of Series I shares issued by Ryvu Therapeutics S.A., the number of Series I shares to be offered for subscription by Ryvu Therapeutics S.A. and execution of the pricing supplement to the placement agreement
Read More
July 15, 2020 -
Ryvu Therapeutics S.A. concludes a placement agreement and commences the book-building process for an offering by way of private subscription of new Series I ordinary bearer shares issued by Ryvu Therapeutics S.A.
Read More
July 13, 2020 -
Shareholders controlling at least 5% of the vote at the General Meeting of Ryvu Therapeutics S.A. convened on July, 13 2020
Read More
July 13, 2020 -
Resolutions adopted by the General Meeting of Ryvu Therapeutics S.A.
Read More
July 13, 2020 -
Ryvu Therapeutics Strategy for 2020-2022
Read More
June 15, 2020
Report: Current Stock Reports
Title